ICD-9 Code | Description |
---|---|
161.3 | MAL NEO CARTILAGE LARYNX |
161.8 | MALIGNANT NEO LARYNX NEC |
161.9 | MALIGNANT NEO LARYNX NOS |
162.0 | MALIGNANT NEO TRACHEA |
2012 ICD-9-CM Diagnosis Codes 161.* : Malignant neoplasm of larynx A malignant neoplasm arising in the glottic area of the larynx. The vast majority of cases represent squamous cell carcinomas. A primary or metastatic malignant tumor involving the larynx.
A primary or metastatic malignant tumor involving the larynx. The majority are carcinomas. ICD-10-CM C32.9 is grouped within Diagnostic Related Group (s) (MS-DRG v38.0): 011 Tracheostomy for face, mouth and neck diagnoses or laryngectomy with mcc
ICD-9-CM codes are used in medical billing and coding to describe diseases, injuries, symptoms and conditions. ICD-9-CM 161.9 is one of thousands of ICD-9-CM codes used in healthcare. Although ICD-9-CM and CPT codes are largely numeric, they differ in that CPT codes describe medical procedures and services.
This is the American ICD-10-CM version of C32.9 - other international versions of ICD-10 C32.9 may differ. All neoplasms are classified in this chapter, whether they are functionally active or not. An additional code from Chapter 4 may be used, to identify functional activity associated with any neoplasm.
161.9 is a legacy non-billable code used to specify a medical diagnosis of malignant neoplasm of larynx, unspecified. This code was replaced on September 30, 2015 by its ICD-10 equivalent.
The GEMs are the raw material from which providers, health information vendors and payers can derive specific applied mappings to meet their needs.